Cigna CFO says push to control specialty drug costs drove Express Scripts acquisition

Skyrocketing specialty drug costs were a primary reason behind Cigna’s decision to purchase Express Scripts, even though the insurer has an in-house pharmacy benefit manager, Cigna’s chief financial officer said on Tuesday.

Continue reading on Fierce Healthcare.